Frederick Appelbaum, MD, executive vice president and professor in the clinical research division at Fred Hutch Cancer C...
US-based Organon, a global healthcare company with deep expertise in biosimilars, and Korea's Samsung Bioepis have annou...
Maxona Pharmaceuticals has received U.S. FDA clearance of its Investigational New Drug application for a Phase 2 clinica...
Lakewood-Amedex Biotherapeutics has announced preclinical safety data supporting clinical dose selection for its upcomin...
Cell therapy is approaching a defining transition: from highly specialised science to a reproducible, scalable pharmaceu...
The pharmaceutical industry’s innovation equation is changing. Developing an entirely new molecu...
As BioSpectrum Asia reports on the ground from BIO Asia–Taiwan 2026, being held from July 15–19 in T...
Versiti, Inc., a nonprofit organization dedicated to improving blood health for patients everywhere, has joined the Bloo...
MEDIPOST has treated the first U.S. participant in its Phase III clinical trial evaluating an investigational mesenchyma...
China-based startup OTR Therapeutics has entered into a strategic collaboration agreement with Korean company LG Chem to...
Artificial intelligence is rapidly reshaping the way biopharma companies discover, develop, and manufacture medicines. H...
RoosterBio and Qkine have entered a distribution agreement to provide U.S. customers with a single-source platform for c...
Catalent and Nanoscope Therapeutics have expanded their partnership to support late-phase clinical development and comme...
FibroBiologics has completed manufacturing of the third batch of CYWC628 drug product for its ongoing Phase 1/2 clinical...
Insilico Medicine has initiated a Phase III clinical trial of rentosertib, its AI-discovered oral small-molecule TNIK in...
REPROCELL has submitted an application for manufacturing and marketing approval in Japan for Stemchymal, a regenerative ...
As cell and gene therapies progress from promising research to commercial reality, manufacturing has emerged as ...
The rapid expansion of in vivo gene therapy is reshaping expectations for viral vector manufacturing, placing greater em...
UniXell Biotechnology has received U.S. FDA Investigational New Drug clearance for UX-DA003, its allogeneic induced plur...
The Australian government is providing more than $15 million to Monash University and Atisama Therapeutics to revolution...
Despite causing millions of serious infections and hundreds of thousands of deaths each year, fungal diseases continue t...
During BIO 2026 in San Diego, BioSpectrum Asia spoke with Kurt Imhof, Senior Vice President, Policy & Public Affairs...
As obesity treatment enters a new phase of innovation, the industry is increasingly looking beyond GLP-1 therapies to ad...
As obesity treatment evolves beyond weight loss toward comprehensive cardiometabolic disease management, pharmaceutical ...
China-based Abbisko Therapeutics has entered into a strategic research collaboration and licence agreement with US-based...
